DarioHealth (NSDQ:DRIO) announced that it launched Dario Move, a digital physical therapy platform for musculoskeletal (MSK) conditions. With the introduction of the Dario Move, Boston-based Dario adds to its suite of chronic condition management platforms that include treatments for diabetes, behavioral health and metabolic health, according to a news release.

MIAMI – The University of Miami is one of 17 sites for a nationwide study into a new treatment for ischemic stroke. The Masters-2 study is investigating a stem cell therapy called MultiStem that could expand the window for treating stroke from the current three hours to up to 36 hours. “The fact that we are […]

Lineage Cell Therapeutics Inc. (NYSE AMERICAN: LCTX) (TASE: LCTX) recently provided an update on its lead program OpRegen®, a cell replacement therapy for dry age-related macular degeneration (AMD) with geographic atrophy (GA). Lineage is pioneering a new branch of medicine, which is manufacturing differentiated cell types and transplanting those cells into the body, to restore or improve function which […]